Literature DB >> 18208477

Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma.

M Carrozzo1.   

Abstract

Morbidity associated with hepatitis C virus (HCV) infection is due not only to the sequelae of chronic liver disease, but also to a variety of extraheaptic manifestations (EHM). Some of the most frequently reported EHM of HCV infection involves the oral region predominantly or exclusively and they are the topics of this 2-part review. The current part 1 discusses the evidences on the association of salivary glands disorders with HCV. HCV- infected patients may frequently have histological signs of Sjögren-like sialadenitis with mild or even absent clinical symptoms. However, the pathogenetic role of HCV in Sjogren Syndrome (SS) development and the characteristics distinguishing classic SS from HCV-related sialadenitis are still an issue. It is unclear if the virus may cause a disease mimicking primary SS or if HCV is directly responsible for the development of SS in a specific subset of patients. Notably, some patients may present a triple association between HCV, SS-like sialadenitis and salivary gland lymphoma and the virus may be involved in the lymphomagenesis. The risk of having a salivary gland lymphoma is particularly high in patients with mixed cryoglobulinemia. Little attention has been paid to the effects of anti-HCV treatment on sialadenitis or lymphoma development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208477     DOI: 10.1111/j.1601-0825.2007.01436.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  16 in total

Review 1.  Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.

Authors:  Deng-Ho Yang; Ling-Jun Ho; Jenn-Haung Lai
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 2.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

Review 3.  Viruses and salivary gland disease (SGD): lessons from HIV SGD.

Authors:  L Jeffers; J Y Webster-Cyriaque
Journal:  Adv Dent Res       Date:  2011-04

4.  Dental problems delaying the initiation of interferon therapy for HCV-infected patients.

Authors:  Yumiko Nagao; Michio Sata
Journal:  Virol J       Date:  2010-08-17       Impact factor: 4.099

Review 5.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

Review 6.  Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

Authors:  Carlo Palazzi; Emilio D'Amico; Salvatore D'Angelo; Michele Gilio; Ignazio Olivieri
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 7.  Oral manifestations of hepatitis C virus infection.

Authors:  Marco Carrozzo; Kara Scally
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

8.  Association Between Hepatitis C Virus and Head and Neck Cancers.

Authors:  Parag Mahale; Erich M Sturgis; David J Tweardy; Ella J Ariza-Heredia; Harrys A Torres
Journal:  J Natl Cancer Inst       Date:  2016-04-13       Impact factor: 13.506

Review 9.  Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials.

Authors:  Lejla Mahmutović; Esma Bilajac; Altijana Hromić-Jahjefendić
Journal:  Microorganisms       Date:  2021-05-06

10.  Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases.

Authors:  Yumiko Nagao; Kouji Hashimoto; Michio Sata
Journal:  BMC Gastroenterol       Date:  2012-11-02       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.